-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

IMBRUVICA® in Frontline CLL/SLL: A Case-based Approach

Sponsor: Pharmacyclics LLC, An AbbVie Company
Program: Product Theaters
Monday, December 7, 2020: 10:30 AM-11:30 AM
Imbruvica in Frontline CLL/SLL: A Case-Based Approach

Imran Khan, MD

Janssen Biotech, Inc., Horsham, PA
See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>